Source: Myeloma – Hematology Advisor
Researchers sought to determine whether ocular toxicity occurred in a significant number of patients with multiple myeloma treated with belantamab mafodotin.
Read More
by | Jul 21, 2022 | Myeloma News | 0 comments
Source: Myeloma – Hematology Advisor
Researchers sought to determine whether ocular toxicity occurred in a significant number of patients with multiple myeloma treated with belantamab mafodotin.
Read More